Biotherapeutics
Blacksburg
About Biotherapeutics
BioTherapeutics Inc. (BTI) is a pre-clinical stage company developing novel small-molecule drugs to treat inflammation associated with autoimmune related disorders and type 2 diabetes (T2D)
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $800.0K
- Last round: Grant (Jun 2017)
- Website: biotherapeuticsinc.com
- Phone: (540) 449-1533
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/biotherapeutics-89559 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.